Delivery Order SPE2DB22D2206-SPE2DB24FGE81
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $3,520.76 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,502,370 units of the Typhim VI 25 mcg/0.5 mL syringe vaccine. The contract, which does not have a set-aside designation, has an ultimate completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,238.62 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,246,745 units of the vaccine Typhim VI 25 mcg/0.5 mL syringe. The contract has an ultimate completion date of May 15, 2025 and is not set aside for any specific business category. AmerisourceBergen is an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to supply 4,564,435,268 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $6,213.76 firm fixed-price contract has an ultimate completion date of April 30, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,176 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a ceiling value of $37,452.40 and a period of performance through April 8, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,979,969 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $6,268.05 delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as the sole prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,439.57, is a delivery order for the supply of 4,563,296,422 units of the Typhim VI 25 mcg/0.5 mL syringe 0.5 mL vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of January 11, 2024. It is not designated with a set-aside requirement, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,567,267,232 units of the TYPHIM VI 25 MCG/0.5 ML syringe 0.5 ML vaccine. The contract has a firm fixed-price pricing type and a ceiling value of $19,652.71. It does not have a set-aside designation, indicating open competition. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 4,564,145,812 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a ceiling value of $4,158.25 and a performance period through April 3, 2024. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.40 firm-fixed-price delivery order is for the supply of 4,566,352,405 units of the Typhim VI 25 mcg/0.5 mL syringe vaccine. The contract has a period of performance through November 7, 2024 and was awarded on November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...